Exelixis Profit Margin

Exelixis's profit margin stands at 33.75% as of September 2026. That compares with 29.63% in the prior-year period — up 13.9% year over year. That is above the Healthcare sector average of 9.48%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Exelixis reported 33.75% in profit margin versus 29.63% a year earlier — a 13.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Exelixis sits higher the Healthcare benchmark (9.48%) with a profit margin of 33.75%. That is roughly 256.0% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 33.75% for Exelixis means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Exelixis's profit margin evolved across reporting periods, while the comparison chart places EX9.DE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.